logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Ş

Şendağ Yaslıkaya

cukurova university faculty of medicine
H指数:3
被引数:22

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre-Treatment CD44 and CD47 Expression and Pathological Complete Response After Neoadjuvant Therapy in Breast Cancer: An Exploratory Single-Center Study

术前CD44和CD47表达与乳腺癌新辅助治疗后的病理完全缓解：一项探索性单中心研究

International Journal of Molecular Sciences
IF4.9
2026-10-290
OA
Hatice Asoglu; Esra Asarkaya; Abdurrahman Aykut; Gunes Dorukhan Cavusoglu; Yasemin Aydinalp Camadan; Mehmet Mutlu Kidi; Sedat Biter; Sendag Yaslikaya; Ramazan Asoglu; Tolga Koseci
Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?

是否存在一个肿瘤比例评分阈值，在该阈值下，肿瘤细胞PD-L1能够为大型B细胞淋巴瘤的国际预后指数提供额外的预后信息？

Diagnostics
IF3.3
2026-09-190
OA
Mehmet Mutlu Kidi; Suheda Atas Ipek; Sendag Yaslikaya; Mahmut Buyuksimsek; Mehmet Turker; Yasemin Aydinalp Camadan; Sedat Biter; Tolga Koseci; Tugba Toyran; Melek Ergin; Berksoy Sahin; Ismail Oguz Kara; Ertugrul Bayram
Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

avelumab维持治疗转移性尿路上皮癌的预后因素

Immunotherapy
IF2.3
2026-09-020
PRE
Caner Kapar; Oğuzcan Özkan; Eda Eylemer Mocan; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Kaan Helvacı; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Bekir Mert Durukan; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yakup Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Mesut Yılmaz; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Mustafa Erman; Yüksel Ürün; Deniz Tural
EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study

EZH2表达及免疫检查点抑制剂治疗非小细胞肺癌患者的临床结局：一项真实世界回顾性队列研究

Journal of Clinical Medicine
IF2.9
2026-09-010
OA
Esra Asarkaya; Hatice Asoglu; Abdurrahman Aykut; Gunes Dorukhan Cavusoglu; Yasemin Aydınalp; Sendag Yaslıkaya; Suheda Atas Ipek; Fatma Calkan; Emine Kilic Bagir; Derya Gumurdulu; Hulya Binokay; Tolga Koseci; Ismail Oguz Kara; Berksoy Sahin; Ertugrul Bayram
Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

晚期胸腺癌二线治疗的实际疗效：一项多中心土耳其肿瘤学组（TOG）研究

BMC Cancer
IF3.4
2026-08-270
OA
Fatih Kus; Fatih Atalah; Gokhan Sahin; Caner Kapar; Damla Gunenc; Erkut Demirciler; Alper Topal; Halil Goksel Guzel; Yakup Duzkopru; Mert Erciyestepe; Ilgin Koc Kus; Omer Denizhan Tatar; Firat Sirvan; Gozde Agdas; Bilgesah Kilictas; Irem Ugurlu; Abdussamet Celebi; Goncagul Akdag; Dogan Bayram; Aysegul Merc Cetinkaya; Ilknur Deliktas Onur; Taliha Guclu; Omer Faruk Elcicek; Sendag Yaslikaya; Elif Sahin; Pinar Gursoy; Ozturk Ates; Abdullah Sakin; Harun Muglu; Murad Guliyev; Nigar Rustamova Cennet; Melike Ozcelik; Melek Karakurt Eryilmaz; Ahmet Bilici; Nebi Serkan Demirci; Mehmet Ali Sendur; Saadettin Kilickap; Derya Kivrak Salim; Ozlem Er; Gamze Gokoz Dogu; Serdar Karakaya; Hasan Cagri Yildirim; Mustafa Erman
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study

索拉非尼治疗放射性碘难治性分化型甲状腺癌患者的真实世界结果及预后因素：一项多中心研究

Journal of Clinical Medicine
IF2.9
2026-06-240
OAAI
Suheda Atas Ipek; Sendag Yaslikaya; Ismail Oguz Kara; Tolga Koseci; Ertugrul Bayram; Esra Asarkaya; Hatice Asoglu; Mehmet Turker; Abdurrahman Aykut; Seda Jeral Evinc; Ozkan Alan; Mehmet Emin Yilmaz; Ozturk Ates; Hatime Arzu Yasar; Mehmet Kayaalp; Esra Asik; Atila Yildirim; Burcu Bacak; Meltem Baykara; Dicle Yurdatap Koc; Muhammed Bekir Hacioglu; Suleyman Alkan; Ferhat Ekinci; Ahmet Burak Agaoglu; Mesut Yilmaz; Ilhan Hacibekiroglu; Mustafa Karaca; Taliha Guclu Kantar; Gamze Gokoz Dogu; Tuba Karacelik; Melek Karakurt Eryilmaz; Teoman Sakalar; Sedat Biter; Mehmet Mutlu Kıdı; Yasemin Aydınalp Camadan; Mahmut Buyuksimsek
Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors

解剖学定位对侵袭性纤维瘤病系统性炎症标志物和免疫检查点CD47的影响

Journal of Clinical Medicine
IF2.9
2026-05-240
OA
Sendag Yaslikaya; Suheda Atas Ipek; Ipek Balikci Cicek; Esra Asarkaya; Hatice Asoglu; Muzeyyen Asli Ergozoglu; Mehmet Turker; Yasemin Aydinalp Camadan; Mehmet Mutlu Kidi; Sedat Biter; Tolga Koseci; Kivilcim Eren Ates; Ertugrul Bayram; Gulfiliz Gonlusen; Ismail Oguz Kara
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)

在HER2阳性转移性乳腺癌中达到“无疾病证据”的临床意义：土耳其肿瘤学组（TOG）开展的多中心研究

Cancers
IF4.4
2026-03-120
OAAI
Bengü Dursun; Şendağ Yaslıkaya; Serhat Sekmek; Tuğba Önder; Hasan Çağrı Yıldırım; Ömer Acar; Nadiye Sever; Savaş Gökçek; Sercan Ön; Ferit Aslan; Gül Sema Keskin; Zehra Sucuoğlu İşleyen; Gözde Savaş; Mehmet Emin Kalender; Semra Paydaş; Öznur Bal; Ülkü Yalçıntaş Arslan; Mustafa Şahbazlar; Burcu Çakar; Hacı Mehmet Türk; Hakan Akbulut
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

avelumab维持治疗在真实世界扩展性准入计划中的转移性尿路上皮癌患者中的应用

Future Oncology
IF2.6
2025-10-160
PRE
Deniz Tural; Oğuzcan Özkan; Eda Eylemer Mocan; Caner Kapar; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Mustafa Erman; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yaküp Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Serkan Yaşar; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Yüksel Ürün
Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG)

帕博西利在脂肪肉瘤中的应用：土耳其肿瘤学组（TOG）的真实世界多中心数据

JOURNAL OF CHEMOTHERAPY
IF1.8
2025-09-010
PRE
Kus, Fatih; Yildirim, Hasan Cagri; Bayram, Dogan; Bal, Oznur; Sahin, Gokhan; Ugrakli, Muzaffer; Demiray, Atike Gokcen; Alan, Ozkan; Koc Kus, Ilgin; Sirvan, Firat; Yildirim, Nilgun; Unal, Olcun Umit; Yaslikaya, Sendag; Sahin, Elif; Sakalar, Teoman; Atalah, Fatih; Karhan, Ogur; Enki, Serkan; Kilickap, Saadettin; Akin, Serkan
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

比较一线FOLFIRINOX与基于氟尿嘧啶和基于吉西他滨的化疗在转移性壶腹腺癌中的疗效：一项由土耳其肿瘤学组（TOG）进行的多中心研究

Journal of Clinical Medicine 2025, Vol. 14, Page 5868
IF2.9
2025-08-230
PRE
Ali Kalem; Tulay Kus; Savas Gokcek; Ilkay Tugba Unek; Taha Koray Sahin; Omer Dizdar; Muhammed Fatih Sagıroglu; Hatice Bolek; Yuksel Urun; Sendag Yaslıkaya; Ertugrul Bayram; Nadiye Sever; Ibrahim Vedat Bayoğlu; Omer Acar; Atike Pınar Erdogan; Seray Saray; Berkan Karabuga; Ulku Arslan Yalcıntas; Safa Can Efil; Mehmet Ali Nahit Sendur; Talat Aykut; Murat Araz; Tugce Kubra Gunes; Melike Ozcelik; Mustafa Seyyar; Gokmen Aktas; Suayib Yalcın
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

黑色素瘤的辅助和一线转移治疗的预后因素和结果土耳其肿瘤学组研究

SCIENTIFIC REPORTS
IF3.9
2025-01-250
OAAI
Majidova, Nargiz; Arak, Haci; Ozalp, Faruk Recep; Bas, Onur; Koker, Gulhan Ozcelik; Ozmarasali, Erkan Buket; Karateke, Yasemin Sagdic; Sakalar, Teoman; Yaslikaya, Sendag; Onur, Ilknur Deliktas; Akdag, Goncagul; Ogul, Ali; Guliyev, Murad; Sahin, Elif; Delipoyraz, Ebru Engin; Alkan, Ali; Aydin, Okan; Ilhan, Nurullah; Alan, Ozkan; Akbas, Sinem; Caglar, Yaprak; Guren, Ali Kaan; Sever, Nadiye; Ellez, Halil Ibrahim; Selcukbiricik, Fatih; Atci, Mustafa Muhammed; Bilici, Ahmet; Demirci, Nebi Serkan; Basoglu, Tugba; Karacin, Cengiz; Kara, Ismail Oguz; Yildiz, Bulent; Evrensel, Turkkan; Karaca, Mustafa; Dizdar, Omer; Atag, Elif; Ozgun, Alpaslan; Kostek, Osman
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

细胞周期蛋白依赖性激酶抑制剂后依维莫司加激素治疗的疗效; 现实生活经验，TOG研究

BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-08-090
PRE
Beypinar, Ismail; Demir, Hacer; Yaslikaya, Sendag; Koseci, Tolga; Demir, Bilgin; Colak, Gokhan; Agaoglu, Ahmet Burak; Sahbazlar, Mustafa; Sanci, Pervin Can; Cabuk, Devrim; Isik, Ulas; Sahin, Elif; Coskun, Alper; Caner, Burcu; Aykut, Talat; Artac, Mehmet; Duygulu, Mustafa Emre; Sever, Nadiye; Oksuz, Sila; Turan, Nedim; Aykan, Musa Baris; Tuzun, Esmanur Kaplan; Uysal, Mukremin; Ugurlu, Irem; Sakin, Abdullah; Acar, Caner; Ozaskin, Duygu; Sakalar, Teoman; Keskinkilic, Merve; Yavuzsen, Tugba; Kose, Naziyet; Erturk, Ismail; Yildirim, Nilgun; Balcik, Onur Yazdan; Alkan, Ali; Selvi, Oguzhan; Ercin, Eda; Unal, Olcun Umit; Karacin, Cengiz
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma

辅助PD-1抑制剂在手术切除的III/IV期肢端黑色素瘤患者中的有效性

JOURNAL OF IMMUNOTHERAPY
IF2.9
2024-03-112
OAAI
Arak, Haci; Erkilic, Suna; Yaslikaya, Sendag; Mocan, Eda Eylemer; Aktas, Gokmen; Ozdemir, Melek; Semiz, Huseyin Salih; Kilickap, Saadettin; Ozalp, Faruk Recep; Sever, Ozlem Nuray; Akdag, Goncagul; Agaoglu, Ahmet Burak; Ozcelik, Melike; Sari, Murat; Arcagok, Murat; Anik, Hicran; Yayla, Saziye Burcak; Sever, Nadiye; Acar, Fatma Pinar; Bayrakci, Ismail; Turhal, Serdar; Ayhan, Murat; Kus, Tulay

研究方向

暂未获取到该数据
Y
Yasemin Aydınalp Camadan
H 指数:2论文数:20被引数:12
M
Mehmet Mutlu Kıdı
H 指数:3论文数:39被引数:32
E
Ertuğrul Bayram
H 指数:8论文数:123被引数:275
G
Goncagül Akdağ
H 指数:5论文数:53被引数:85
S
Sedat Biter
H 指数:4论文数:47被引数:38
İ
İsmail Oğuz Kara
H 指数:13论文数:90被引数:484
B
Berksoy Şahin
H 指数:20论文数:123被引数:1,517
A
Abdullah Sakin
H 指数:14论文数:158被引数:680
F
Fatih Atalah
H 指数:3论文数:14被引数:17
M
Murad Guliyev
H 指数:5论文数:52被引数:60